Analysts expect CG Oncology, Inc. to report revenue of 579,812.39 for Q3 26, against a range of 540,070.89 to 619,553.89. The most recent reported quarter, Q2 26, came in at 1.16 M, a 234.8% beat against the 346,498.47 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 43,000.00 | 459,000.00 | 52,000.00 | 0.00 | 1.67 M | 2.31 M | 1.08 M | 1.16 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 119,643.72 | 105,356.62 | 194,663.87 | 114,903.39 | 62,322.13 | 498,368.04 | 497,578.87 | 365,195.87 | 619,553.89 | 571,965.46 | 0.00 | 11.45 M | 13.55 M | 13.11 M | 88.50 M | 101.29 M | ||||||||||
| Low Estimate | 111,863.90 | 94,991.60 | 168,133.59 | 100,714.65 | 53,824.61 | 464,435.94 | 454,934.83 | 327,801.07 | 540,070.89 | 517,319.32 | 0.00 | 9.88 M | 12.58 M | 11.53 M | 80.52 M | 91.84 M | ||||||||||
| Consensus Estimate | 115,753.81 | 100,174.11 | 181,398.73 | 107,809.02 | 58,073.37 | 481,401.99 | 476,256.85 | 346,498.47 | 579,812.39 | 544,642.39 | 0.00 | 10.66 M | 13.07 M | 12.32 M | 84.51 M | 96.56 M |
Analysts expect CG Oncology, Inc. to report earnings per share of -0.87 for Q3 26, against a range of -0.93 to -0.81. The most recent reported quarter, Q2 26, came in at -0.90, a 40.6% miss against the -0.64 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.30 | -0.46 | -0.45 | -0.54 | -0.57 | -0.55 | -0.71 | -0.90 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.31 | -0.36 | -0.38 | -0.42 | -0.55 | -0.57 | -0.56 | -0.59 | -0.81 | -0.75 | -0.89 | -0.73 | -0.78 | -0.78 | -0.31 | -0.19 | ||||||||||
| Low Estimate | -0.35 | -0.38 | -0.40 | -0.50 | -0.61 | -0.67 | -0.62 | -0.69 | -0.93 | -0.87 | -0.99 | -0.87 | -0.92 | -0.96 | -0.35 | -0.23 | ||||||||||
| Consensus Estimate | -0.33 | -0.37 | -0.39 | -0.46 | -0.58 | -0.62 | -0.59 | -0.64 | -0.87 | -0.81 | -0.94 | -0.80 | -0.85 | -0.87 | -0.33 | -0.21 |
Pull Wall Street consensus for CG Oncology, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CGON&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CGON", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CGON&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();